David Garcia

Dr. David Garcia is an Academic Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine. He also serves as the Associate Medical Director of Anti-Thrombotic Therapy at UW Medicine. His clinical practice is based at the Fred Hutchinson Cancer Center - South Lake Union in Seattle, Washington.

Dr. Garcia's primary research and clinical interests focus on thrombotic disorders, with particular expertise in antiphospholipid syndrome and cancer-associated venous thromboembolism. His work spans the fields of hematology, oncology, and anticoagulation therapy, with a strong emphasis on evidence-based approaches to thrombosis prevention and management.

His extensive publication record, with over 190 articles spanning from 2002 to 2025, demonstrates sustained contributions to the understanding and treatment of thrombotic disorders. His research has evolved from foundational work on anticoagulants to more recent studies on direct oral anticoagulants, classification criteria for antiphospholipid syndrome, and specialized anticoagulation management in complex patient populations including those with cancer and renal disease.

Dr. Garcia has contributed to major clinical guidelines including the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines on antithrombotic therapy and the ACR/EULAR Antiphospholipid Syndrome Classification Criteria. His work often appears in high-impact journals such as The New England Journal of Medicine, Circulation, and Blood.

His clinical expertise includes management of anemia, bleeding disorders, blood disorders, cellular hematology, clotting disorders, and cytopenia, with a specialized focus on complex thrombotic conditions requiring sophisticated anticoagulation strategies.